TRANSIENT ELEVATION OF AST OR LDH AS AN EARLY PHARMACODYNAMIC BIOMARKER OF RECOMBINANT CIRCULARLY PERMUTED TRAIL (CPT) IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
单位：[1]Beijing Sunbio Biotech Co Ltd, Beijing, Peoples R China[2]Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China北京朝阳医院[3]Inst Hematol, State Key Lab Expt Hematol, Beijing, Peoples R China[4]Blood Dis Hosp, Beijing, Peoples R China[5]Second Mil Med Univ, Chang Zheng Hosp, Shanghai, Peoples R China[6]Hebei Med Univ, Hosp 2, Shijiazhuang, Peoples R China[7]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[8]Peking Univ, Hosp 3, Beijing 100871, Peoples R China[9]Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China四川大学华西医院
Wei P.,Yang S.,Zheng X.,et al.TRANSIENT ELEVATION OF AST OR LDH AS AN EARLY PHARMACODYNAMIC BIOMARKER OF RECOMBINANT CIRCULARLY PERMUTED TRAIL (CPT) IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA[J].HAEMATOLOGICA.2014,99:369-369.
APA：
Wei, P.,Yang, S.,Zheng, X.,Chen, W.,Qiu, L....&Pang, H..(2014).TRANSIENT ELEVATION OF AST OR LDH AS AN EARLY PHARMACODYNAMIC BIOMARKER OF RECOMBINANT CIRCULARLY PERMUTED TRAIL (CPT) IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA.HAEMATOLOGICA,99,
MLA：
Wei, P.,et al."TRANSIENT ELEVATION OF AST OR LDH AS AN EARLY PHARMACODYNAMIC BIOMARKER OF RECOMBINANT CIRCULARLY PERMUTED TRAIL (CPT) IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA".HAEMATOLOGICA 99.(2014):369-369
医学